Antibiotics Producer Warns ‘Buy European’ Rules Could Create Quasi-Monopoly

Dutch antibiotics producer Centrient is warning that a careless implementation of the “Buy European” criteria in the EU’s recently agreed Critical Medicines Act (CMA) could decrease competition in the antibiotics market, especially for amoxicillin

Published on Aug 25, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.